APINI THERAPEUTICS LIMITED

13767202
Active Huntingdon

Research and experimental development on biotechnology

1 employees website.com
Research and experimental development on biotechnology
A

APINI THERAPEUTICS LIMITED

13767202

Research and experimental development on biotechnology

Founded 26 Nov 2021 Active Huntingdon, England 1 employees website.com
Research and experimental development on biotechnology
Accounts Submitted 23 Jul 2025 Next due 31 Dec 2026 6 months remaining
Confirmation Submitted 5 Dec 2025 Next due 9 Dec 2026 5 months remaining
Net assets £1M £1M 2024 year on year
Total assets £1M £1M 2024 year on year
Total Liabilities £266K £3K 2024 year on year
Charges None No charges registered

Contact & Details

Contact

Registered Address

Burnham House Splash Lane Wyton Huntingdon PE28 2AF England

Full company profile for APINI THERAPEUTICS LIMITED (13767202), an active company based in Huntingdon, England. Incorporated 26 Nov 2021. Research and experimental development on biotechnology. View financials, directors, shareholders, and filings.

Business Summary

This company specializes in providing innovative solutions and services across multiple sectors.

Products & Services

consulting software analytics integration

Reports

Credit Report

In-depth credit score, financial analysis, risk assessment and company intelligence.

Financials

Financials

Period 1 Apr → 31 Mar 2025
Type small
Next accounts 31 Mar 2026
Due by 31 Dec 2026 6 months remaining

Net Assets, Total Assets & Total Liabilities (2022–2024)

Cash in Bank

£1.08M

Net Assets

£1.06M

Increased by £1.16M (+1154%)

Total Liabilities

£265.51k

Increased by £2.56k (+1%)

Turnover

N/A

Employees

1

Debt Ratio

20%

Decreased by 142 (-88%)

Financial History

Revenue, profit, EBITDA and key financial figures

2025
31 Mar Year End
2023
30 Nov Year End
P&L
Revenue
£142.3M
£128.7M
Gross Profit
£48.2M
£43.1M
Operating Profit
£22.4M
£19.8M
Net Profit
£18.1M
£15.9M
EBITDA
£31.5M
£28.2M
Assets
Cash
£24.7M
£21.3M
Total Assets
£89.4M
£82.1M
Liabilities
Total Liabilities
£45.2M
£41.8M
Key Metrics
Employees
1,247
1,156
Latest Revenue
£142.3M
Latest EBITDA
£31.5M
Cash Position
£24.7M

Funding

Fundraising & Grants

No fundraising or grants recorded

Investors (0)

No investor information available

Share Capital

Share Capital

Share allotments and capital structure

7 Allotments 5,236,143 Shares £10.40m Total
Date FromShare ClassShares AllottedAmount RaisedPrice/Share
8 Jul 20252,000,000£4.00m£2
8 Jul 20252,000,000£4.00m£2
13 Aug 2024185,144£296k£1.6
13 Aug 20241,050,000£2.10m£2
27 Jul 202275£0.75£0.01

Officers

Officers

3 active
Status
Isaac, John Timothy Roger, DrDirectorBritishUnited Kingdom577 Nov 2025Active
James GibbonsDirectorBritishEngland3627 Mar 2025Active
Sam ButterworthDirectorBritishEngland4726 Nov 2021Active

Shareholders

Shareholders (9)

Slingshot Therapeutics Holdings Limited
57.6%
2,440,000
Northern Gritstone Limited
14.4%
610,000

Persons with Significant Control

Persons with Significant Control (1)

1 Active 1 Ceased
Notified 13 Aug 2024
Nature of Control
  • Ownership Of Shares 50 To 75 Percent,voting Rights 50 To 75 Percent

Sam Butterworth

Ceased 13 Aug 2024

Ceased

Group Structure

Group Structure

APINI THERAPEUTICS LIMITED Current Company

Charges

Charges

No charges registered

Properties

Properties

0 total

No related properties

Documents

Company Filings

DateCategoryDescriptionDocument
5 Dec 2025Confirmation StatementConfirmation statement made on 25 Nov 2025 with updates
14 Nov 2025OfficersTermination of Richard Wooster as director on 7 Nov 2025
14 Nov 2025OfficersAppointment of Dr John Timothy Roger Isaac as director on 7 Nov 2025
29 Jul 2025Change Of NameReplacement filing of SH01 - 08/07/25 Statement of Capital gbp 42.35144
24 Jul 2025Persons With Significant ControlChange to Slingshot Therapeutics Holdings Limited as a person with significant control on 8 Jul 2025
5 Dec 2025 Confirmation Statement

Confirmation statement made on 25 Nov 2025 with updates

14 Nov 2025 Officers

Termination of Richard Wooster as director on 7 Nov 2025

14 Nov 2025 Officers

Appointment of Dr John Timothy Roger Isaac as director on 7 Nov 2025

29 Jul 2025 Change Of Name

Replacement filing of SH01 - 08/07/25 Statement of Capital gbp 42.35144

24 Jul 2025 Persons With Significant Control

Change to Slingshot Therapeutics Holdings Limited as a person with significant control on 8 Jul 2025

Recent Activity

Latest Activity

Confirmation statement made on 25 Nov 2025 with updates

6 months ago on 5 Dec 2025

Termination of Richard Wooster as director on 7 Nov 2025

7 months ago on 14 Nov 2025

Appointment of Dr John Timothy Roger Isaac as director on 7 Nov 2025

7 months ago on 14 Nov 2025

Replacement filing of SH01 - 08/07/25 Statement of Capital gbp 42.35144

10 months ago on 29 Jul 2025

Change to Slingshot Therapeutics Holdings Limited as a person with significant control on 8 Jul 2025

11 months ago on 24 Jul 2025